Literature DB >> 33514373

Tracking the time course of pathological patterns of lung injury in severe COVID-19.

Thais Mauad1, Amaro Nunes Duarte-Neto2, Luiz Fernando Ferraz da Silva2,3, Ellen Pierre de Oliveira4, Jose Mara de Brito2, Ellen Caroline Toledo do Nascimento2, Renata Aparecida de Almeida Monteiro2, Juliana Carvalho Ferreira4, Carlos Roberto Ribeiro de Carvalho4, Paulo Hilário do Nascimento Saldiva2, Marisa Dolhnikoff2.   

Abstract

BACKGROUND: Pulmonary involvement in COVID-19 is characterized pathologically by diffuse alveolar damage (DAD) and thrombosis, leading to the clinical picture of Acute Respiratory Distress Syndrome. The direct action of SARS-CoV-2 in lung cells and the dysregulated immuno-coagulative pathways activated in ARDS influence pulmonary involvement in severe COVID, that might be modulated by disease duration and individual factors. In this study we assessed the proportions of different lung pathology patterns in severe COVID-19 patients along the disease evolution and individual characteristics.
METHODS: We analysed lung tissue from 41 COVID-19 patients that died in the period March-June 2020 and were submitted to a minimally invasive autopsy. Eight pulmonary regions were sampled. Pulmonary pathologists analysed the H&E stained slides, performing semiquantitative scores on the following parameters: exudative, intermediate or advanced DAD, bronchopneumonia, alveolar haemorrhage, infarct (%), arteriolar (number) or capillary thrombosis (yes/no). Histopathological data were correlated with demographic-clinical variables and periods of symptoms-hospital stay.
RESULTS: Patient´s age varied from 22 to 88 years (18f/23 m), with hospital admission varying from 0 to 40 days. All patients had different proportions of DAD in their biopsies. Ninety percent of the patients presented pulmonary microthrombosis. The proportion of exudative DAD was higher in the period 0-8 days of hospital admission till death, whereas advanced DAD was higher after 17 days of hospital admission. In the group of patients that died within eight days of hospital admission, elderly patients had less proportion of the exudative pattern and increased proportions of the intermediate patterns. Obese patients had lower proportion of advanced DAD pattern in their biopsies, and lower than patients with overweight. Clustering analysis showed that patterns of vascular lesions (microthrombosis, infarction) clustered together, but not the other patterns. The vascular pattern was not influenced by demographic or clinical parameters, including time of disease progression.
CONCLUSION: Patients with severe COVID-19 present different proportions of DAD patterns over time, with advanced DAD being more prevalent after 17 days, which seems to be influenced by age and weight. Vascular involvement is present in a large proportion of patients, occurs early in disease progression, and does not change over time.

Entities:  

Keywords:  COVID-19; Diffuse alveolar damage; Lung pathology; Minimally invasive autopsy; Pulmonary thrombosis

Year:  2021        PMID: 33514373     DOI: 10.1186/s12931-021-01628-9

Source DB:  PubMed          Journal:  Respir Res        ISSN: 1465-9921


  7 in total

1.  Morphometry of the human pulmonary vasculature.

Authors:  W Huang; R T Yen; M McLaurine; G Bledsoe
Journal:  J Appl Physiol (1985)       Date:  1996-11

2.  Severe glomerular C3 deposition indicates severe renal lesions and a poor prognosis in patients with immunoglobulin A nephropathy.

Authors:  Jianliang Wu; Zhizhi Hu; Yuxi Wang; Danni Hu; Qian Yang; Yueqiang Li; Wei Dai; Fengming Zhu; Juan Yang; Meng Wang; Han Zhu; Liu Liu; Xiaofeng He; Min Han; Ying Yao; Guangchang Pei; Rui Zeng; Gang Xu
Journal:  Histopathology       Date:  2021-03-13       Impact factor: 5.087

3.  The pulmonary vascular lesions of the adult respiratory distress syndrome.

Authors:  J F Tomashefski; P Davies; C Boggis; R Greene; W M Zapol; L M Reid
Journal:  Am J Pathol       Date:  1983-07       Impact factor: 4.307

Review 4.  Pulmonary pathology and COVID-19: lessons from autopsy. The experience of European Pulmonary Pathologists.

Authors:  Fiorella Calabrese; Federica Pezzuto; Francesco Fortarezza; Paul Hofman; Izidor Kern; Angel Panizo; Jan von der Thüsen; Sergei Timofeev; Gregor Gorkiewicz; Francesca Lunardi
Journal:  Virchows Arch       Date:  2020-07-09       Impact factor: 4.064

5.  "Obesity Paradox" in Acute Respiratory Distress Syndrome: Asystematic Review and Meta-Analysis.

Authors:  Guo Zhi; Wang Xin; Wang Ying; Xing Guohong; Liu Shuying
Journal:  PLoS One       Date:  2016-09-29       Impact factor: 3.240

6.  Does Coronavirus Disease 2019 Disprove the Obesity Paradox in Acute Respiratory Distress Syndrome?

Authors:  Ricardo J Jose; Ari Manuel
Journal:  Obesity (Silver Spring)       Date:  2020-06       Impact factor: 5.002

7.  Pulmonary and systemic involvement in COVID-19 patients assessed with ultrasound-guided minimally invasive autopsy.

Authors:  Amaro N Duarte-Neto; Renata A A Monteiro; Luiz F F da Silva; Denise M A C Malheiros; Ellen P de Oliveira; Jair Theodoro-Filho; João R R Pinho; Michele S Gomes-Gouvêa; Ana P M Salles; Ilka R S de Oliveira; Thais Mauad; Paulo H N Saldiva; Marisa Dolhnikoff
Journal:  Histopathology       Date:  2020-07-24       Impact factor: 7.778

  7 in total
  16 in total

Review 1.  Neutrophil Extracellular Traps (NETs) in Severe SARS-CoV-2 Lung Disease.

Authors:  Monika Szturmowicz; Urszula Demkow
Journal:  Int J Mol Sci       Date:  2021-08-17       Impact factor: 5.923

2.  Chronic lung lesions in COVID-19 survivors: predictive clinical model.

Authors:  Carlos Roberto Ribeiro Carvalho; Rodrigo Caruso Chate; Marcio Valente Yamada Sawamura; Michelle Louvaes Garcia; Celina Almeida Lamas; Diego Armando Cardona Cardenas; Daniel Mario Lima; Paula Gobi Scudeller; João Marcos Salge; Cesar Higa Nomura; Marco Antonio Gutierrez
Journal:  BMJ Open       Date:  2022-06-13       Impact factor: 3.006

3.  What remains in the pulmonary tissue after acute COVID-19?

Authors:  Amaro Nunes Duarte-Neto; Marisa Dolhnikoff
Journal:  J Bras Pneumol       Date:  2022-07-08       Impact factor: 2.800

4.  Can lung ultrasound predict histologic pattern of lung injury in critically ill patients with COVID-19? Author's reply.

Authors:  Renata Aparecida de Almeida Monteiro; Amaro Nunes Duarte-Neto; Paulo Hilário Nascimento Saldiva; Marisa Dolhnikoff
Journal:  Intensive Care Med       Date:  2021-03-12       Impact factor: 17.440

5.  Minimally Invasive Tissue Sampling Findings in 12 Patients With Coronavirus Disease 2019.

Authors:  Natalia Rakislova; Maria Teresa Rodrigo-Calvo; Lorena Marimon; Inmaculada Ribera-Cortada; Mamudo R Ismail; Carla Carrilho; Fabiola Fernandes; Melania Ferrando; Esther Sanfeliu; Paola Castillo; José Guerrero; José Ramírez-Ruz; Karmele Saez de Gordoa; Ricardo López Del Campo; Rosanna Bishop; Estrella Ortiz; Abel Muñoz-Beatove; Jordi Vila; Juan Carlos Hurtado; Mireia Navarro; Maria Maixenchs; Vima Delgado; Iban Aldecoa; Antonio Martinez-Pozo; Pedro Castro; Clara Menéndez; Quique Bassat; Miguel J Martinez; Jaume Ordi
Journal:  Clin Infect Dis       Date:  2021-12-15       Impact factor: 9.079

6.  Ultrasound-Guided Minimally Invasive Tissue Sampling: A Minimally Invasive Autopsy Strategy During the COVID-19 Pandemic in Brazil, 2020.

Authors:  Amaro Nunes Duarte-Neto; Luiz Fernando Ferraz da Silva; Renata Aparecida de Almeida Monteiro; Jair Theodoro Filho; Thabata Larissa Luciano Ferreira Leite; Catia Sales de Moura; Michele Soares Gomes-Gouvêa; João Renato Rebellho Pinho; Cristina Takami Kanamura; Ellen Pierre de Oliveria; Kely Cristina Soares Bispo; Cássia Arruda; Aline Brito Dos Santos; Flavia Cristina Gonçalves Aquino; Elia Garcia Caldini; Thais Mauad; Paulo Hilário Nascimento Saldiva; Marisa Dolhnikoff
Journal:  Clin Infect Dis       Date:  2021-12-15       Impact factor: 9.079

7.  Targeting chronic COVID-19 lung injury; Tofacitinib can be used against tissue-resident memory T cells.

Authors:  Sepideh Zununi Vahed; Seyed Mahdi Hosseiniyan Khatibi; Elham Ahmadian; Mohammadreza Ardalan
Journal:  Biomed Pharmacother       Date:  2022-01-04       Impact factor: 6.529

8.  Extended minimally invasive autopsy: Technical improvements for the investigation of cardiopulmonary events in COVID-19.

Authors:  Jair Theodoro-Filho; Renata Aparecida de Almeida Monteiro; Amaro Nunes Duarte-Neto; Thais Mauad; Luiz Fernando Ferraz da Silva; Paulo Hilário Nascimento Saldiva; Marisa Dolhnikoff
Journal:  Clinics (Sao Paulo)       Date:  2021-11-26       Impact factor: 2.365

9.  Viral mapping in COVID-19 deceased in the Augsburg autopsy series of the first wave: A multiorgan and multimethodological approach.

Authors:  Klaus Hirschbühl; Sebastian Dintner; Martin Beer; Claudia Wylezich; Jürgen Schlegel; Claire Delbridge; Lukas Borcherding; Jirina Lippert; Stefan Schiele; Gernot Müller; Dimitra Moiraki; Oliver Spring; Michael Wittmann; Elisabeth Kling; Georg Braun; Thomas Kröncke; Rainer Claus; Bruno Märkl; Tina Schaller
Journal:  PLoS One       Date:  2021-07-19       Impact factor: 3.240

Review 10.  Therapeutic implications of ongoing alveolar viral replication in COVID-19.

Authors:  Dennis McGonagle; Mary F Kearney; Anthony O'Regan; James S O'Donnell; Luca Quartuccio; Abdulla Watad; Charles Bridgewood
Journal:  Lancet Rheumatol       Date:  2021-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.